enVVeno MedicalNVNO +3.27%26 EBIT per Share is $-33.33 as of Mar. 2026. GuruFocus rates NVNO with a GF Score™ of 26/100. The stock has 3 warning signs investors should review. Among 688 Medical Devices & Instruments companies, enVVeno Medical ranks better than 68.02% on this metric.
enVVeno Medical's EBIT per Share for the
three
months ended in Mar. 2026 was $-6.21.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-33.33.
During the past 3 years, the average EBIT per Share Growth Rate was 23.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 26.50% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 20.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for enVVeno Medical's EBIT per Share or its related term are showing as below:
NVNO'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -90.4 Med: 23.35 Max: 53.7
Current: 23
During the past 11 years, the highest 3-Year average EBIT per Share Growth Rate of enVVeno Medical was 53.70% per year. The lowest was -90.40% per year. And the median was 23.35% per year.
NVNO's 3-Year EBIT Growth Rate is ranked better than 68.02% of 688
companies
in the Medical Devices & Instruments industry
Industry Median: 9.5
vs NVNO: 23.00
enVVeno Medical's EBIT for the
three
months ended in Mar. 2026 was $-4.06 Mil.
enVVeno Medical (NAS:NVNO) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
enVVeno Medical EBIT per Share Related Terms
enVVeno Medical EBIT per Share Historical Data
* Premium members only.
The historical data trend for enVVeno Medical's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-33.33
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
enVVeno Medical (NVNO) has a EBIT per Share of $-33.33 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on enVVeno Medical and its competitors. According to the industry distribution chart, enVVeno Medical ranks #220 out of 688 companies in the Medical Devices & Instruments industry, placing it in the top 32%.
Is enVVeno Medical's EBIT per Share too high?
enVVeno Medical's current EBIT per Share is $-33.33. Based on the distribution chart, enVVeno Medical ranks #220 out of 688 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, enVVeno Medical has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does enVVeno Medical's EBIT per Share compare to STME and TRIB?
According to the Medical Devices & Instruments industry distribution chart, enVVeno Medical ranks #220 out of 688 companies for EBIT per Share. This puts enVVeno Medical in the upper half of its industry. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on enVVeno Medical and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. enVVeno Medical's current EBIT per Share is $-33.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is enVVeno Medical stock overvalued right now?
enVVeno Medical (NVNO) has a current EBIT per Share of $-33.33. The current EBIT per Share is $-33.33. enVVeno Medical's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For enVVeno Medical (NVNO), the current EBIT per Share is $-33.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
26GF Score
Get the complete analysis for NVNO
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVNO has been successfully added to your 
